Last reviewed 2026-04-20 · How we verify

EPHEDRINE HYDROCHLORIDE

At a glance

Approved indications

No approved indications tracked.

Common side effects

• Nausea
• Tachycardia
• Vomiting
• Palpitations
• Dizziness
• Restlessness

Serious adverse events

• Reactive hypertension
• Bradycardia
• Ventricular ectopics
• R-R variability

Key clinical trials

• Effect of Systemic Inflammatory Index and Systemic Immune Inflammation Index on Ecchymosis, Bleeding and Edema
• Restrictive vs Liberal Intraoperative Fluid Strategy and Postoperative Outcomes After Elective Cesarean Section (NA)
• Changes of Ciprofol Dosage and Bispectral Index Required for Loss of Consciousness in Patients of Different Ages
• Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above (PHASE4)
• Use of Vasopressors in Hypotension Associated With Spinal Anaesthesia in Caesarean Sections (NA)
• Norepinephrine With Ephedrine Versus Norepinephrine Alone During Spinal Anesthesia for Cesarean Delivery (PHASE4)
• Hemodynamics During Cesarean Delivery Under Spinal Anesthesia With Norepinephrine Versus Ephedrine (PHASE4)
• Noradrenaline Versus Standard Blood Pressure Management for Perioperative Hypotension in Non-cardiac Surgery (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• EPHEDRINE HYDROCHLORIDE CI brief — competitive landscape report
• EPHEDRINE HYDROCHLORIDE updates RSS · CI watch RSS